Endocrinology
From the Journals
Cardiac CT scans can be used for osteoporosis screening
The “results represent a step toward appraisal and recognition of the clinical utility of opportunistic BMD screening from cardiac CT.”
From the Journals
Medical societies advise on vitamin D in midst of COVID-19
Preliminary results show for the first time that vitamin D intake may be tied to decreased risk for immunotherapy-induced colitis in patients with...
Latest News
Hyperglycemia predicts COVID-19 death even without diabetes
This finding came from a retrospective analysis of 605 patients with COVID-19 seen at two hospitals in Wuhan, China.
From the Journals
Delayed diagnoses seen in children during COVID-19
"Pediatricians on the frontline know what to expect with diabetes. Those children who would have come in late prior to the pandemic are now...
From the Journals
Captopril questioned for diabetes patients in COVID-19 setting
Captopril appears to be associated with a higher rate of pulmonary adverse reactions in patients with diabetes than that of other ACE inhibitors...
From the Journals
Cushing’s and COVID-19: Nontraditional symptoms keys to assessment, treatments
Features of Cushing’s syndrome may confound diagnosis and treatment of COVID-19, and also could make patients more susceptible to the pandemic.
From the Journals
Zoledronic acid fails to impact abdominal aortic calcification
Women with osteoporosis experienced no difference in AAC progression on yearly zoledronic acid.
News
FDA approves first oral somatostatin analog for acromegaly
The oral drug octreotide offers an alternative to long-term injections for the rare chronic disease.
Conference Coverage
High-impact training can build bone in older women
“The takeaway here is that this type of exercise appears to be a highly effective therapy to reduce risk of osteoporotic fracture, since it...
Latest News
Ignored by doctors, transgender people turn to DIY treatments
Conference Coverage
Dapagliflozin benefits low-EF heart failure regardless of diuretic dose: DAPA-HF
The trial that turned an SGLT2 inhibitor into a heart failure drug also has clues to mechanisms behind the observed benefits. Contrary to early...